E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/15/2008 in the Prospect News Special Situations Daily.

Odyssey HealthCare, VistaCare to combine

By Lisa Kerner

Charlotte, N.C., Jan. 15 - Odyssey HealthCare, Inc. agreed to acquire VistaCare, Inc. for $8.60 per share, or approximately $147.1 million.

The transaction is expected to close in the first quarter.

A termination fee of $4.4 million is included in the agreement, according to a form 8-K filing with the Securities and Exchange Commission.

The transaction is structured as a two-step acquisition: a cash tender offer for outstanding shares of VistaCare common stock will be followed by a cash merger in which Odyssey would acquire any remaining outstanding VistaCare shares.

"This transaction is a turning point for Odyssey as we expect to exceed $617 million in net revenues, improve our platform for growth in our core hospice business and add valuable and talented professionals to our company," Odyssey president and chief executive officer Robert A. Lefton said in a company news release.

"Our combination with VistaCare will substantially extend our industry leadership and our geographical reach in the markets we serve and create additional visibility that adds value in recruiting and development activities," Lefton added.

Expected synergies include a reduction in corporate overhead and the closure of VistaCare's corporate office.

Odyssey plans to fund the transaction with $30 million of its own cash and a funded commitment of $150 million from GE Capital, consisting of a five-year $30 million revolving credit facility and a six-year $120 million term loan, the release stated.

Both VistaCare and Odyssey are hospice care providers. VistaCare is located in Scottsdale, Ariz., and Odyssey is based in Dallas.

Acquirer:Odyssey HealthCare, Inc.
Target:VistaCare, Inc.
Announcement date:Jan. 15
Transaction total:$147.1 million
Price per share:$8.60
Termination fee:$4,413,500
Expected closing:First quarter of 2008
Stock price of target:Nasdaq: VSTA: $7.16 on Jan. 14

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.